Randox Announce Three Biochip Arrays for the Detection of a Variety of Antimicrobial Agents

27 Sept 2009
Sarah Sarah
Marketing / Sales

Product news

Randox have developed three biochip arrays for the detection of a variety of antimicrobial agents. These arrays enable simultaneous multi-analyte testing of up to 12 antimicrobials from a single sample. Antimicrobial Array I tests for sulphonamides, Array II for general antibiotics and Array III for nitrofurans, chloramphenicol and malachite green.

These antimicrobials are extensively used in human and veterinary medicine and their use in food producing animals could result in potentially harmful concentrations in tissue, organs and milk. This can lead to allergies for example to sulphonamide drugs which are relatively common and include skin rash, hives and anaphylaxis. Maximum residue limits have been set for the majority of these anti-microbial agents therefore screening on a regular basis is imperative.

Randox revolutionary biochip array technology is based on established ELISA principles utilising competitive chemiluminescent immunoassays. The biochip contains an array of immobilised antibodies each specific to a different antimicrobial. With as little as 50µl of urine or one gram of tissue, the antimicrobial analytes on each array can be analysed concurrently. The antimicrobial arrays are analysed on the semi-automated Evidence Investigator generating 540 tests in less than two hours. These arrays all provide excellent sensitivity, precision and recovery.

The antimicrobial arrays provide a sensitive and quantitative screening test for various antimicrobials. Randox innovative biochip array technology provides a multitude of choice for all your screening needs.

Links

Tags

Microarray AnalysisMicroarrays, also known as biochips, are used for the detection and analysis of multiple genes, proteins, antibodies, or biomarkers on a single microchip. This can reveal information on protein or gene expression, single nucleotide polymorphism (SNP), copy number variation (CNV), epigenetics and patient health in clinical diagnostic tests. Discover a range of microarray scanners and prefabricated antibody, protein, RNA and DNA microarrays for your analysis or consider creating your own custom microarrays with a microarray printer. Find the best microarray products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.
Randox Announce Three Biochip Arrays for the Detection of a Variety of Antimicrobial Agents